Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC

Cyclacel Pharmaceuticals (CYCC) Stock Investors

576 Followers
Based on 687,026 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CYCC
On average, investors allocate 2.20% of their portfolios to CYCC
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 687,026 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CYCC

1.2%
Last 7
Days
0.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CYCC, out of 687,026 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CYCC Investor Activity

No data currently available
Based on the activity of 12,700 investors who made their portfolios public
The table shows changes in CYCC in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CYCC Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.11%
+0.53%
-1.91%
38.15B
Healthcare
Coherus Biosciences
2.55%
-1.32%
+774.37%
457.37M
Healthcare
Assertio Therapeutics
3.14%
-1.20%
-5.89%
234.63M
Healthcare
Delta Air Lines
5.66%
-1.16%
-4.37%
24.64B
Industrials
Nikola
6.33%
+1.18%
-0.69%
1.11B
Energy
Syros Pharmaceuticals
4.13%
-1.71%
-7.28%
81.80M
Healthcare
Micron
5.65%
+0.30%
-2.39%
74.37B
Technology
Tilray
3.80%
-0.87%
-2.98%
1.73B
Healthcare
Blink Charging Co
4.23%
+0.34%
+2.15%
204.27M
Utilities
AMC Entertainment
5.25%
-0.77%
+28.73%
1.53B
Consumer Cyclical
Based on the activity of 687,026 active portfolios
Open your Smart Portfolio

CYCC Investor Analysis

CYCC investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.0%
of CYCC holders
are under 35
Average Segment Performance
Average P/E Ratio-28.27
Beta9.48
Dividend Yield5.31%
CYCC investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
32.6%
of CYCC holders
are between 35–55
Average Segment Performance
Average P/E Ratio-25.67
Beta14.52
Dividend Yield18.48%
CYCC investors over 55

Over 55

1.4%
Last 30 days
Holdings Change
60.5%
of CYCC holders
are over 55
Average Segment Performance
Average P/E Ratio-18.77
Beta5.45
Dividend Yield5.10%
Overview of age group and performance of CYCC stock investors
See who invests in CYCC according to age group and performance.

FAQ

How many retail Investors hold CYCC?
<0.1% of TipRank’s retail investors hold CYCC in their portfolios.
    What is CYCC Investor Sentiment?
    CYCC’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of CYCC in the last 7 days?
      ▼ 1.2% of TipRank’s retail investors changed their holding of CYCC in the last 7 days.
        What percentage of retail investors changed their holding of CYCC in the last 30 days?
        ▼ 0.6% of TipRank’s retail investors changed their holding of CYCC in the last 30 days.
          What is the average age of retail investors who hold CYCC?
          The average age of CYCC Holders is over 55.
            What other stocks have CYCC investors also bought?
            CYCC Investors also bought MRNA, CHRS, ASRT, DAL, NKLA, SYRS, MU, TLRY, BLNK, AMC.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AMRNAmarin
              BSXBoston Scientific
              CNCCentene
              CHRSCoherus Biosciences

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis